Post-approval studies (Phase 4)UnknownNCT00838019What this trial is testingIntrabone Cord Blood TransplantationWho this might be right forHematological Malignancies Hospital Clinic of Barcelona 10
Testing effectiveness (Phase 2)WithdrawnNCT04016116What this trial is testingDual PD-1 and JAK2 Inhibition in Hematological MalignanciesWho this might be right forCancerHematological Malignancy NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT07220616What this trial is testingA First-in-Human Trial of DS3790a in Participants With Hematological MalignanciesWho this might be right forHematological Malignancies Daiichi Sankyo 420
Testing effectiveness (Phase 2)UnknownNCT01332006What this trial is testingIntra-bone Cord Blood TransplantationWho this might be right forHematologic Neoplasms Università degli Studi di Brescia 17
Not applicableUnknownNCT05780411What this trial is testingCancer Survivorship in Hematologic MalignanciesWho this might be right forCancer Survivors Assiut University 80
Very early researchNot Yet RecruitingNCT04657965What this trial is testingLMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological MalignanciesWho this might be right forInfectious DiseasesHematological Malignancies Zhejiang University 144
Early research (Phase 1)Study completedNCT04634435What this trial is testingAutologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma PatientsWho this might be right forMultiple Myeloma Biohaven Pharmaceuticals, Inc. 7
Not applicableActive Not RecruitingNCT06849921What this trial is testingPrecise Design of Cell Therapy for Relapsed and Refractory Hematological TumorsWho this might be right forPrecise Design of Cell Therapy for Relapsed and Refractory Hematological TumorsHematologic Disease Ruijin Hospital 200
Testing effectiveness (Phase 2)WithdrawnNCT03739606What this trial is testingFlotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood CancerWho this might be right forAcute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00038857What this trial is testingMegadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant DiseasesWho this might be right forLeukemiaLymphoma M.D. Anderson Cancer Center 29
Not applicableNot Yet RecruitingNCT06674330What this trial is testingUsing a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical IllnessWho this might be right forHematological MalignanciesCritical Illness National Taiwan University Hospital 600
Early research (Phase 1)Ended earlyNCT00963495What this trial is testingStudy Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+4 more University Health Network, Toronto 11
Testing effectiveness (Phase 2)Study completedNCT00077922What this trial is testingAnti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphocyticChronic National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT01527045What this trial is testingDonor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological MalignanciesWho this might be right forAggressive Non-Hodgkin LymphomaBlasts Under 5 Percent of Bone Marrow Nucleated CellsChronic Lymphocytic Leukemia+18 more Fred Hutchinson Cancer Center 47
Large-scale testing (Phase 3)Looking for participantsNCT07007312What this trial is testingStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLWho this might be right forAcute Myeloid Leukemia (AML) Kura Oncology, Inc. 1,300
Not applicableStudy completedNCT00290641What this trial is testingChemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+1 more Masonic Cancer Center, University of Minnesota 68
Testing effectiveness (Phase 2)Looking for participantsNCT03850366What this trial is testingHLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and BortezomibWho this might be right forHematological Malignancy Henry Ford Health System 15
Not applicableStudy completedNCT02834156What this trial is testingImpact of Child Positioning on Pain During a Lumbar PunctureWho this might be right forHematological Malignancies Centre Hospitalier Universitaire de Nice 28
Testing effectiveness (Phase 2)Study completedNCT01517035What this trial is testingImproving Blood Stem Cell Collection and Transplant ProceduresWho this might be right forMyelodysplastic Syndrome (MDS)Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia+2 more National Heart, Lung, and Blood Institute (NHLBI) 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04977024What this trial is testingSARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood CancerWho this might be right forCOVID-19 InfectionHematopoietic and Lymphoid System NeoplasmLeukemia+2 more GeoVax, Inc. 63